Background: Despite increasing prevalence of illicit fentanyl use in the US and Canada,
preference for fentanyl over other illicit opioids has not been fully characterized. Therefore, we …

Background and Aims Injecting illicit drugs in public settings has been linked to a higher risk
of a range of drug-related harms, including overdose and HIV infection. However, the …

Background Although the harms of prescription drug diversion are of growing international
concern, the potential impact of prescription drug use on HIV infection has not been well …

Background: Supervised consumption facilities (SCFs) are evidence-based harm reduction
interventions that have been shown to reduce the risk of social and health-related harms …

Addiction recently published a research report on maternal and infant characteristics
associated with maternal opioid overdose in the year following delivery1. We commend and …

Background Rates of opioid use disorder and opioid overdose during pregnancy and in the
postpartum period are increasing. While methadone remains a cornerstone of treatment for …

Women who use drugs (WWUD) experience high rates of trauma. The complex impacts of
trauma can act as a barrier to accessing substance use and harm reduction services, and to …

Background: Using a clinical case example, we describe and discuss the use of oral naltrexone
as a novel treatment strategy for nitrous oxide use. Nitrous oxide is an inhalant drug that …

Also known as liquid ecstasy or “G,” GHB and its analogues (eg, γ-butyrolactone) are GHB-and
γ-aminobutyric acid-B (GABA B) receptor agonists within the central nervous system. 1–3 …

Among HIV-positive people who use illicit drugs (PWUD) in our setting, repeated periods of
incarceration adversely affect ART adherence in a dose-dependent manner. However, the …